Leadership Team

Robert Sambursky, MD

Robert P. Sambursky, MD
Founder, Chief Executive Officer, and President

Robert Sambursky has been a member of RPS’s executive leadership team as the Chief Medical Officer and served on the company’s Board of Directors since co-founding the company in 2004. In addition, he served as both President and Executive Chairman before being appointed the additional roles of CEO and Chairman. Sambursky currently serves on several pharmaceutical advisory boards. He earned his BA from Brown University, MA from Boston University, and MD from Boston University School of Medicine. Sambursky completed his medical internship at Mount Auburn Hospital and both his ophthalmology residency and cornea fellowship at Wills Eye Hospital in Philadelphia.


Robert W. VanDine
Founder and Chief Government Affairs Officer

Robert VanDine co-founded RPS during his tenure as President of Securetec Contraband Detection and Identification, Inc., the U.S. subsidiary of Securetec from 1996 to 2007. In this position, VanDine was responsible for the manufacture and marketing of lateral flow chromatography biosensors for the security, law enforcement, and medical device markets. Since 2007, VanDine has led the development of the RPS’s intellectual property portfolio and the company’s U.S. Government contracting efforts. He currently serves as Chief Government Affairs Officer. VanDine earned his BS from the U.S. Naval Academy.

Pete Grady WebPeter Grady
Chief Financial Officer

Peter Grady has more than 20 years of financial management experience across a variety of manufacturing companies with worldwide operations. Grady’s most recent experience was with Becton Dickinson, where he led the finance function for the Biosciences segment, which develops, manufactures, markets, and sells diagnostic tests for HIV and cancer. Grady has facilitated the success of both private and public organizations ranging in size from $20 million to more than $1 billion in revenue. He also spent a number of years as an expatriate in Switzerland while integrating the acquisition of a Swiss company. Grady has previously held Board positions with non-profit organizations focused on charity efforts. Grady earned his MBA from the University of San Diego.


Peter J. Condon, PhD
Vice President of Technology

Peter Condon has managed research and product development (R&D) efforts in diagnostic and biotech start-up companies as well as in larger established organizations including Meridian Bioscience, Immunetics Inc., Formatech Inc., and Daktari Diagnostics. Condon has successfully developed a wide variety of diagnostic products for use in point-of-care and reference laboratory settings. Specifically, he has expertise in immunoassay and microfluidic product development as well as significant experience in product development from the concept stage through regulatory approval in the U.S. and Europe. In addition to his R&D responsibilities, Condon is currently providing oversight for quality and regulatory affairs. Condon earned his BA from Brown University and PhD from the University of Massachusetts.


Robert W. Gergen
Vice President of Global Sales

Robert Gergen has nearly 24 years of successful sales and marketing experience in the medical diagnostic industry, with over 20 years in the point-of-care test market. Bob served in various sales leadership roles at Quidel Corporation, most recently at the helm of the sales department as Director of North American Sales since 2005. Under Bob’s leadership at Quidel, U.S. sales experienced exponential growth from $50 million to $100 million during a three-year period. He began his career as a sales representative for Johnson & Johnson Professional Diagnostics, moving on to sell surgical lasers for use in operating rooms for Sun Medical, Inc. Additional positions focused on national and corporate accounts and distributor relations, key to penetrating the primary care physician markets. Gergen earned his BA from Oklahoma City University.


Christopher Allen Michaels
Vice President of Strategic Development and Technology Licensing

Chris Michaels has more than 20 years of successful intellectual property law experience with Brown & Michaels, PC, where he has served as managing partner since 1994. Prior to joining RPS, his years of experience as RPS’s patent attorney and expertise in the biotechnology field facilitated an intimate knowledge and understanding of the RPS technology platform. At RPS, Michaels strengthens the company’s intellectual property position, assesses competitive landscapes, supports product pipeline partnership licensing, and assesses future technology out-licensing opportunities. He has also published articles in legal, patent, and technology journals and has edited several books on patent and trademark practice. Michaels earned his BA from Bucknell University, his JD from Syracuse University, an MBA at the University of Pennsylvania’s Wharton School and is currently working toward a Management Science and Engineering Graduate Certificate at Stanford University.


Kurt Phinney
Senior Director of Manufacturing

Kurt Phinney has 15 years of experience leading biomedical project management and manufacturing. Phinney’s background includes development of biochemical assays (lateral flow, ELISA, western blot, and cell-based) with the State Laboratory Institute of Massachusetts, Immunetics, and Floria Biosystems. His ongoing pursuit of novel biotechnology has resulted in multiple patents and FDA clearances. Phinney also provided consultation to biotechnology, information technology, and pharmaceutical firms in the U.S. and overseas. Prior to this, he served as a Health Service Corpsman with the United States Coast Guard. Phinney received a BS in Biology from the State University of New York at Albany.


Michelle Parker WebMichelle Parker
Senior Director of Corporate Communications

Michelle Parker has held strategic communications leadership roles with two of the world’s most respected medical device companies, Johnson & Johnson and GE Healthcare. She led both organizations through extensive issue/crisis management, enterprise-wide change management, market development, and global mergers/acquisitions and divestitures. In her recent role with J&J Vision Care, Parker delivered communications counsel to the CEO, elevated the leadership team as thought leaders in the ophthalmology/optometric industries, and delivered strategic media, government and investor relations to support the turnaround of the U.S. business and to accelerate growth globally. In her role at GE Healthcare, she helped launch healthymagination, GE’s innovative health and wellness platform designed to lower healthcare costs, increase access, and improve quality of care across the globe. Based on her measurable results, Parker was appointed as the communications lead of a newly formed, $9 billion GE Healthcare interventional surgery business in Buc, France. Parker earned her BA in Communications from the University of Wisconsin.